NRXP Other: a positive outcome, +5.6%

On January 16, 2026, NRX Pharmaceuticals, Inc. reached its Other. The result was a positive outcome, and the stock moved +5.6% in the window around the event. It had already run -6.6% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.